Trial Profile
Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2010
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Pharmacokinetics
- 25 Feb 2009 New trial record